Over 120 reports on cutting edge companies developing anti-cancer therapeutics, from big pharma companies to small pioneering biotech companies. Our Corporate Oncology Pipeline Updates reports on all phases of development from drug discovery to marketed products. For each company report you can evaluate: * Drugs on market * Overview of R&D Pipeline, including drugs, indications and developmental stage. * Pursued targets * Mechanism strategy * Extensive drug profiles including: